» Articles » PMID: 23283992

Uric Acid-induced Phenotypic Transition of Renal Tubular Cells As a Novel Mechanism of Chronic Kidney Disease

Overview
Specialties Nephrology
Physiology
Date 2013 Jan 4
PMID 23283992
Citations 119
Authors
Affiliations
Soon will be listed here.
Abstract

Recent experimental and clinical studies suggest a causal role of uric acid in the development of chronic kidney disease. Most studies have focused on uric acid-induced endothelial dysfunction, oxidative stress, and inflammation in the kidney. The direct effects of uric acid on tubular cells have not been studied in detail, and whether uric acid can mediate phenotypic transition of renal tubular cells such as epithelial-to-mesenchymal transition (EMT) is not known. We therefore investigated whether uric acid could alter E-cadherin expression and EMT in the kidney of hyperuricemic rats and in cultured renal tubular cells (NRK cells). Experimental hyperuricemia was associated with evidence of EMT before the development of significant tubulointerstitial fibrosis at 4 wk, as shown by decreased E-cadherin expression and an increased α-smooth muscle actin (α-SMA). Allopurinol significantly inhibited uric acid-induced changes in E-cadherin and α-SMA with an amelioration of renal fibrosis at 6 wk. In cultured NRK cells, uric acid induced EMT, which was blocked by the organic anion transport inhibitor probenecid. Uric acid increased expression of transcriptional factors associated with decreased synthesis of E-cadherin (Snail and Slug). Uric acid also increased the degradation of E-cadherin via ubiquitination, which is of importance since downregulation of E-cadherin is considered to be a triggering mechanism for EMT. In conclusion, uric acid induces EMT of renal tubular cells decreasing E-cadherin synthesis via an activation of Snail and Slug as well as increasing the degradation of E-cadherin.

Citing Articles

Establishment and optimization of a novel mouse model of hyperuricemic nephropathy.

Wang J, Chen R, Wu K, Mo J, Li M, Chen Z Ren Fail. 2024; 46(2):2427181.

PMID: 39540397 PMC: 11565683. DOI: 10.1080/0886022X.2024.2427181.


Kidney function in newly diagnosed myeloma patients: factors associated with kidney impairment and recovery.

Cesar B, Braga W, Hamerschlak N, Durao Junior M BMC Nephrol. 2024; 25(1):344.

PMID: 39390432 PMC: 11468068. DOI: 10.1186/s12882-024-03717-5.


Targeting Liver by GalNAc-siRNA Is an Effective Strategy for Hyperuricemia Therapy.

Sun H, Wang X, Li Y, Shen Y, Zhang L, Xu Y Pharmaceutics. 2024; 16(7).

PMID: 39065635 PMC: 11279964. DOI: 10.3390/pharmaceutics16070938.


A preliminary probabilistic nomogram model for predicting renal arteriolar damage in IgA nephropathy from clinical parameters.

Wang H, Zhang X, Zhen L, Liu H, Liu X Front Immunol. 2024; 15:1435838.

PMID: 39011045 PMC: 11246907. DOI: 10.3389/fimmu.2024.1435838.


Emerging Roles of Xanthine Oxidoreductase in Chronic Kidney Disease.

Korsmo H, Ekperikpe U, Daehn I Antioxidants (Basel). 2024; 13(6).

PMID: 38929151 PMC: 11200862. DOI: 10.3390/antiox13060712.